Carmustine and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Carmustine (carmustine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Joint pain when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Joint pain?

Joint pain is found to be associated with 3,327 drugs and 5,213 conditions by eHealthMe. Check the latest studies of Joint pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

4,562 people reported to have side effects when taking Carmustine.
Among them, 11 people (0.24%) have Joint pain.

Among these 11 people:

How long have people been on Carmustine when they have Joint pain? *

What is the gender of people who have Joint pain when taking Carmustine? *

female: 30 %
male: 70 %

What is the age of people who have Joint pain when taking Carmustine? *

What are other drugs people take besides Carmustine? *

What are other side effects people have besides Joint pain? *

Disease Progression: 3 people, 27.27%
Acute Kidney Failure: 3 people, 27.27%
Fever: 3 people, 27.27%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 27.27%
Thrombocytopenia (decrease of platelets in blood): 3 people, 27.27%
Haemoglobin Decreased: 3 people, 27.27%
Infection: 2 people, 18.18%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 18.18%
Gallstones (stone formation by bile component): 2 people, 18.18%
Haematocrit Decreased: 2 people, 18.18%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 27.27%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 18.18%
Lymphoma (cancer that begins in immune system cells): 2 people, 18.18%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 18.18%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%
Peripheral T-Cell Lymphoma Unspecified Stage Iii (peripheral t-cell cancer unspecified stage iii): 1 person, 9.09%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 9.09%
Hodgkin's Lymphoma (cancer originating from white blood cells): 1 person, 9.09%
Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 1 person, 9.09%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carmustine:

Carmustine (4,562 reports)

Joint pain treatments and more:

Joint pain (542,936 reports)

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,327 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.